A61P 7/08
Plasma substitutes
Official title: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
A61P7/08 (Plasma substitutes) appears on 1,112 US grants and 1,499 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,112
- Published applications
- 1,499
- Assignees
- 690
- Inventors
- 2,783
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 8 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 7 | 0 |
| 1997 | 16 | 0 |
| 1998 | 30 | 0 |
| 1999 | 17 | 0 |
| 2000 | 15 | 0 |
| 2001 | 24 | 7 |
| 2002 | 31 | 45 |
| 2003 | 17 | 55 |
| 2004 | 25 | 80 |
| 2005 | 19 | 67 |
| 2006 | 36 | 69 |
| 2007 | 38 | 69 |
| 2008 | 31 | 81 |
| 2009 | 38 | 84 |
| 2010 | 42 | 102 |
| 2011 | 46 | 75 |
| 2012 | 70 | 81 |
| 2013 | 61 | 83 |
| 2014 | 60 | 67 |
| 2015 | 56 | 84 |
| 2016 | 64 | 77 |
| 2017 | 46 | 59 |
| 2018 | 46 | 55 |
| 2019 | 42 | 42 |
| 2020 | 37 | 54 |
| 2021 | 33 | 41 |
| 2022 | 27 | 38 |
| 2023 | 16 | 28 |
| 2024 | 19 | 20 |
| 2025 | 20 | 26 |
| 2026 | 3 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fat emulsion dialysate, and preparation method and use thereof9 Jun 2026US 12,648,906 B2Shanghai Superb Medical Technology Co., Ltd
- Implantable pump for direct sodium removal therapy having on-board analyte sensor12 May 2026US 12,623,011 B2DSRCo BV
- Blood substitutes comprising hemoglobin and methods of making24 Mar 2026US 12,582,703 B2VirTech Bio, Inc.
- Methods of administering a pharmaceutically acceptable salt of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate16 Dec 2025US 12,496,308 B2Aeromics, Inc.
- Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction16 Dec 2025US 12,496,384 B2DSRCo BV
- Use of fat emulsion in preparation of peritoneal dialysate for removal of protein-bound toxins3 Sep 2026US 2026/0256693 A1Shanghai Superb Medical Technology Co., Ltd
- Device for treating an individual suffering from cardiac insufficiency, cardiac arrest, circulatory arrest or stroke6 Aug 2026US 2026/0224813 A1Resuscitec GmbH
- Trace element composition, preparation method therefor, and use thereof30 Jul 2026US 2026/0216058 A1Beijing Zangweixinkang Pharmaceutical R&D Co., Ltd.
- Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction23 Jul 2026US 2026/0207835 A1DSRCo BV
- Recombinant hemoglobin9 Jul 2026US 2026/0191936 A1Kangma-Healthcode (Shanghai) Biotech Co., Ltd.
Most cited
By later US patents
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Hemoglobin combined with a poly(alkylene oxide)875US 4,670,417 AAjinomoto Co., Inc. · 1987
- Blood substitute containing modified hemoglobin699US 4,301,144 AAjinomoto Co., Inc. · 1981
- Modified peptides as therapeutic agents359US 6,660,843 B1Amgen Inc. · 2003
- Oxygen carrier252US 4,412,989 AAjinomoto Co., Inc. · 1983